Product Information
HYDROCODONE ER 15 MG CAPSULE is a generic product labeled by Alvogen Inc., priced at $7.9469 per EA under NDC 47781041060. Its NADAC has been published 168 times since Oct 21, 2020.
FDA first approved this application on Jan 21, 2020.
Strength
15 mg/1
Manufacturer
Alvogen Inc.NDC
47781041060
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDROCODONE BITARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA206986FDA Approved
1/21/2020
On Market Since
1/21/2020
Pharmacological Classes
Price Statistics
The NADAC for HYDROCODONE ER 15 MG CAPSULE has been published 168 times since Oct 21, 2020, and over the history we have for it it has risen 3.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.9469 per EA |
|---|---|
| All-time high | $7.9695 (Jul 15, 2026) |
| All-time low | $5.8819 (Sep 18, 2024) |
| 52-week high | $7.9695 |
| 52-week low | $5.9352 |
| Median price | $6.0889 |
| Average price | $6.5227 |
| Largest weekly change | +34.3% (Jun 17, 2026) |
| Weeks tracked | 168 |
| Tracking since | Oct 21, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Hydrocodone Bitartrate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alvogen Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Hydrocodone Bitartrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROCODONE ER 15 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE ER 15 MG CAPSULE, manufactured by Alvogen Inc., is $7.9469 per EA (NDC 47781041060), effective Sep 30, 2026.
How has the price of HYDROCODONE ER 15 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for HYDROCODONE ER 15 MG CAPSULE has risen 3.3%. It has been tracked across 168 weekly CMS publications since Oct 21, 2020.
What are the highest and lowest recorded NADAC prices for HYDROCODONE ER 15 MG CAPSULE?
Since Oct 21, 2020, the NADAC for HYDROCODONE ER 15 MG CAPSULE has ranged from a low of $5.8819 (Sep 18, 2024) to a high of $7.9695 (Jul 15, 2026), with a median of $6.0889 per EA.
Are there cheaper alternatives to HYDROCODONE ER 15 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of HYDROCODONE ER 15 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HYDROCODONE ER 15 MG CAPSULE?
HYDROCODONE ER 15 MG CAPSULE (NDC 47781041060) is labeled by Alvogen Inc., and CMS classifies it as a generic product.